Intravenous chlorpromazine for acute paediatric migraine.
Ruth Mc LöllgenFranz E BablMark T MackayAshley HillGreta M PalmerPublished in: Emergency medicine Australasia : EMA (2022)
While intravenous chlorpromazine as second-line agent was mostly safe, it had unclear efficacy given the requirement for further treatment and hospital admissions.